Challenges in the design of reliable immuno-oncology mouse models to inform drug development
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy
Binding properties of different categories of IDO1 inhibitors: a microscale thermophoresis study
News, Therapeutic challenges, Technologies and methodologies, Spotlight on small molecule immunotherapeutics
A research group from the University of Michigan (Ann Arbor, MI, USA) has found that adding immune T cells to fibroblasts can help to overcome chemotherapy resistance in ovarian cancer.
Histone deacetylase inhibitors could improve success rate of immunotherapy against lung cancer
In celebration of Ada Lovelace Day we speak to L’OREAL-UNESCO Laureate, Pamela Björkman